↓ Skip to main content

Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board

Overview of attention for article published in Targeted Oncology, February 2023
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
10 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board
Published in
Targeted Oncology, February 2023
DOI 10.1007/s11523-023-00950-0
Pubmed ID
Authors

Klara Dorman, Danmei Zhang, Kathrin Heinrich, Laurens Reeh, Lena Weiss, Michael Haas, Georg Beyer, Daniel Rössler, Elisabetta Goni, Bernhard W. Renz, Jan G. D’Haese, Wolfgang G. Kunz, Max Seidensticker, Stefanie Corradini, Maximilian Niyazi, Steffen Ormanns, Jörg Kumbrink, Andreas Jung, Frederick Klauschen, Jens Werner, Julia Mayerle, Michael von Bergwelt-Baildon, Stefan Boeck, Volker Heinemann, C. Benedikt Westphalen

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 1 17%
Student > Doctoral Student 1 17%
Unknown 4 67%
Readers by discipline Count As %
Medicine and Dentistry 2 33%
Unknown 4 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 March 2023.
All research outputs
#6,537,839
of 25,403,829 outputs
Outputs from Targeted Oncology
#97
of 617 outputs
Outputs of similar age
#114,663
of 422,400 outputs
Outputs of similar age from Targeted Oncology
#3
of 10 outputs
Altmetric has tracked 25,403,829 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 617 research outputs from this source. They receive a mean Attention Score of 3.5. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 422,400 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.